Key facts
- Haptiv8’s last known valuation is $2.0M (May 2025).
- It has raised $300K; the latest was Seed Round ($270K) in May 2025.
- Notable investors include UK Innovation & Science Seed Fund, Deepbridge Capital, LYVA Labs.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Haptiv8
- ·The full record, as it builds
Funding rounds
No funding rounds for Haptiv8 are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Haptiv8
Developer of wearable technology designed for therapeutic intervention. The company delivers sensory feedback to encourage natural gait patterns, captures movement data for clinical analysis, and offers features tailored for children, enabling pediatric healthcare providers to personalize rehabilitation strategies, monitor progress remotely, and reduce reliance on invasive treatments.
- Sector
- Healthcare
- HQ
- Wirral, United Kingdom
- Founded
- 2023
- Website
- haptiv8.com/
- Ownership
- Privately Held (backing)
Haptiv8 doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Haptiv8 shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Haptiv8 in its N-PORT filings yet. We sweep new filings monthly.